The following are new and competing renewal awards made to faculty in the Department of Pediatrics for the months of October 2019 through December 2019. Congratulations to these faculty on their awards and best wishes to them in their investigative work.
October 2019
Kaveh Ardalan, MD (Rheumatology) received an award from Childhood Arthritis & Rheumatology Research Alliance, Inc. in the amount of 19,872 for a research study entitled “CARRA Early Investigator Vice Chair Support.” The project period is 10/01/2019 – 06/30/2021.
Rasheed Gbadegesin, MBBS (Nephrology) received an award from Nationwide Children’ in the amount of $105,581 for a research study entitled “CUREGN 2.0 Midwest Pediatric Nephrology Consortium-PCC”. The project period is 07/01/2019-06/30/2024.
Salim Idriss, MD, PhD (Cardiology) received an award from Food and Drug Administration in the amount $333,751 for a research study entitled “CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study”. The project period is 09/30/2019-09/29/2020.
Dwight Koeberl, MD, PhD (Medical Genetics) received an award from Moderna Therapeutics in the amount of $364,669 for a research study entitled “A global Phase 1/2, Open Label Dose Escalation Study to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of mRNA-3704 in Patients with Isolated Methylmalonic Acidemai Due to Methylmalonyl-CoA Mutase Deficiency”. The project period is 10/01/2019-09/30/2023.
Jennifer Peterson, MD (Neonatology) received an award from Prolacta in the amount of $57,275 for a research study entitled “Effects of an Exclusive Human Milk Diet on Enteral Feeding Outcomes of Neonates with Congenital Gastrointestinal Disorders”. The project period is 09/17/2019-11/16/2020.
Jennifer Rothman, MD (Hematology-Oncology) received an award from Novartis (ICON-3) in the amount of $53,275 for a research study entitled “A Phase 3 Study of Eltrombopag vs Standard First-Line Management of Newly Diagnosed Immune Thrombocytopenia (ITP) in children”. The project period is 10/10/2019-06/30/2021.
Jennifer Sherwin, MD (Critical Care Medicine) received an award from Pfizer Inc. in the amount of $329,160 for a research project entitled “CAZ-AVI (Cefazidime-Avibactam)”. The project period is 09/10/2019-09/30/2022.
Baodong Sun, PhD (Medical Genetics) received an award from Asklepios BioPharmaceutical, Inc. in the amount of $208,223 for a research study entitled “Vector Development”. The project period is 10/01/2019-07/31/2020.
Lars Wagner, MD (Hematology-Oncology) received an award from Children’s Hospital of Philadelphia/Pfizer in the amount of $4,500 for a research study entitled “A phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+B-Actue Lymphoblastic Leukemia”. The project period is 06/01/2019-06/30/2026.
Lars Wagner, MD (Hematology-Oncology) received an award from Gradalis, Inc. in the amount of $277,441 for a research project entitled “A Multi-Center Phase III, Randomized Open-Label Trail of Vigil (bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in combination with Irinotecan and Temozolomide as a Second-Regimen for Ewing's Sarcoma”. The project period is 10/01/2019-10/31/2023.
Emmanuel B. Walter, MD (Infectious Diseases) received an award from National Institutes of Health in the amount of $7,894,646 for a research study entitled “Collaborative Influenza Vaccine Innovation Centers (CIVICS) Component C: Clinical Core- Option 16." The project period is 09/16/2019 – 09/15/2022.
November 2019
Kaveh Ardalan, MD (Rheumatology) received an award from Childhood Arthritis & Rheumatology Research Alliance, Inc. in the amount of $25,000 for a research study entitled “Mental Health Screening in Juvenile Myositis: Pilot and Feasibility Study.” The project period is 10/01/2019 – 06/30/2020.
Salim Idriss, MD, PhD (Cardiology) received an award from Food and Drug Administration in the amount of $333,751 for a research study entitled “CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study”. The project period is 09/30/2019-09/29/2020.
Eliana Perrin, MD (Primary Care) received an award from McClay Foundation $186,300 for a research study entitled “Making a Big Difference with Small Items”. The project period is 10/01/2019-09/30/2022.
Suhag Parikh, MBBS (Blood and Marrow Transplantation) received an award from Children’s Hospital - Los Angeles in the amount of $17,463 for a research study entitled “Busulfan Exposure-finding for SCID”. The project period is 05/01/2019-04/30/2022.
Andrew Landstrom, MD, PhD (Cardiology) received an award from American SIDS Institute in the amount of $70,000 for a research project entitled “Cord blood-based biomarker discovery for sudden infant death syndrome risk”. The project period is 03/01/2020- 02/28/2022.
Priya Kishanani, MD, MBBS (Medical Genetics) received an award from Amicus Therapeutics in the amount of $370,474 for a research study entitled “ An Open-Label Study of Pharmacokinetics, Safety, Efficacy, and Pharmacodynamics of ATB200/AT2221 in Pediatric Subjects aged 12 to <18 years with Late Onset Pompe Disease”. The project period is 11/11/2019-12/31/2021.
Muhammad Zafar, MBBS (Neurology) received an award from Stokes Therapeutics in the amount of $70,651 for a research study entitled “An Observational Study to Investigate Cognition and Quality of Life in Children and Adolescents with Dravet Syndrome”. The project period is 10/25/19-03/31/2022.
Muhammad Zafar, MBBS (Neurology) received an award from SK Life Science Inc., in the amount of $125,826 for a research study entitled “ Phase 1, Open-Label Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects with lennox-Gastaut Syndrome “. The project period is 10/31/2019-08/31/2022.
William Malcolm, MD (Neonatology) received an award from MedImmune Inc., in the amount of $193,600 for a research study entitled “A Phase 2/3 Randomized, Double-Blind Palivizumab- controlled Study to Evaluate the Safety of MEDI8897”. The project period is 11/15/2019-12/31/2021.
December 2019
Eric Benner, MD, PhD (Neonatology) received an award from the National Institutes of Health/NINDS in the amount of $2,796,941 for a research project entitled “Mechanisms of Oxysterol-induced Oligodendrogenesis”. The project period is 12/15/19-11/30/2024.
Michael Cohen-Wolkowiez, MD, PhD (Infectious Diseases) received an award from the National Institutes of Health/NIAID in the amount of $115,139 for a research project entitled “TASK AREA A, TASK ORDER FY.2020.A1.0127 - Task Area A (P1CTU-HHSN272201500006I TO10)”. The project period is 12/15/2019- 12/14/2020.
Elizabeth Gifford, PhD, MS (Sanford School of Public Policy) and Lindsay Terrell, MD (Primary Care Pediatrics) received an award from The Duke Endowment in the amount of $286,904 for a research study entitled “Early Identification and Prevention of Child Maltreatment: Cross-Agency Processes and Outcomes”. The project period is 12/01/2019- 11/30/2021.
Corinne Linardic, MD, PhD (Hematology-Oncology) received an award from Alex's Lemonade Stand in the amount of $250,000 for a research study entitled “Role of the Mmacro lncRNA KCNQ1OT1 in Embryonal Rhabdomyosarcoma Tumorigenesis.” The project period is 10/01/2019 – 09/30/2021.
Corinne Linardic, MD, PhD (Hematology-Oncology) received an award from Alex's Lemonade Stand in the amount of $15,521 for a project entitled ”2019 ALSF Million Mile Grant”. The project period is 12/16/2019 -12/15/2020.
Ann Reed, MD (Rheumatology) received an award from the Cynthia and George Mitchell Foundation in the amount of $50,000 for a project entitled ”Duke Children’s Hospital Jump for the Children". The project period is 12/01/19-11/30/2020.
Heather Van Mater, MD (Rheumatology) received an award from the Rheumatology Research Foundation in the amount of $50,000 for a project entitled “ACR/Amgen Rheumatology Fellowship Training Award”. The project period is 07/01/2020 -06/30/2021.
Charlene Wong, MD, MSPH (Primary Care Pediatrics) received an award from DHHS/Centers for Medicare & Medicaid Services in the amount of $2,999,287 in year 1 and up to $16,000,000 for a project entitled “North Carolina Integrated Care for Kids Model”. The project period 01/01/2020-12/31/2026.